Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

HIV-1 Unique Recombinant Forms Identified in Slovenia and Their Characterization by Near Full-Length Genome Sequencing.

Lunar MM, Mlakar J, Zorec TM, Poljak M.

Viruses. 2020 Jan 3;12(1). pii: E63. doi: 10.3390/v12010063.

2.

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.

Oroz M, Begovac J, Planinić A, Rokić F, Lunar MM, Zorec TM, Beluzić R, Korać P, Vugrek O, Poljak M, Lepej SŽ.

Sci Rep. 2019 Nov 21;9(1):17307. doi: 10.1038/s41598-019-53520-8.

3.

Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends.

Lunar MM, Židovec Lepej S, Poljak M.

Infect Genet Evol. 2019 Apr;69:146-152. doi: 10.1016/j.meegid.2019.01.015. Epub 2019 Jan 22.

PMID:
30682549
4.

A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study.

Jakupi X, Mlakar J, Lunar MM, Seme K, Rudhani I, Raka L, Vince A, Poljak M.

BMC Nephrol. 2018 Nov 3;19(1):304. doi: 10.1186/s12882-018-1100-5.

5.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

6.

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.

Lunar MM, Židovec Lepej S, Tomažič J, Vovko TD, Pečavar B, Turel G, Maver M, Poljak M.

PLoS One. 2018 Apr 26;13(4):e0196670. doi: 10.1371/journal.pone.0196670. eCollection 2018.

7.

Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).

Poljak M, Šterbenc A, Lunar MM.

Expert Rev Anti Infect Ther. 2017 Nov;15(11):987-999. doi: 10.1080/14787210.2017.1392854. Epub 2017 Oct 20. Review.

PMID:
29027811
8.

A36 Prevalence of HIV-1 subtypes in Slovenia with an emphasis on molecular and phylogenetic investigation of subtype A.

Mlakar J, Lunar MM, Abecasis AB, Vandamme AM, Tomažič J, Vovko TD, Pečavar B, Volčanšek G, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.035. doi: 10.1093/ve/vew036.035. eCollection 2017 Mar. No abstract available.

9.

A22 Increase in the numbers of HIV-1 non-B subtypes and potential recombinant forms circulating among Slovenian MSM in recent years.

Lunar MM, Mlakar J, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.021. doi: 10.1093/ve/vew036.021. eCollection 2017 Mar. No abstract available.

10.

Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning.

Cuypers L, Libin P, Schrooten Y, Theys K, Di Maio VC, Cento V, Lunar MM, Nevens F, Poljak M, Ceccherini-Silberstein F, Nowé A, Van Laethem K, Vandamme AM.

Infect Genet Evol. 2017 Sep;53:15-23. doi: 10.1016/j.meegid.2017.05.007. Epub 2017 May 9.

PMID:
28499845
11.

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM; HEPVIR Working Group of the European Society for Translational Antiviral Research.

J Infect Dis. 2016 Jan 1;213(1):39-48. doi: 10.1093/infdis/jiv363. Epub 2015 Jul 1.

PMID:
26136470
12.

Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm.

Lunar MM, Matković I, Tomažič J, Vovko TD, Pečavar B, Poljak M.

J Med Virol. 2015 Sep;87(9):1510-6. doi: 10.1002/jmv.24209. Epub 2015 May 12.

PMID:
25970253
13.

Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe.

Lunar MM, Vandamme AM, Tomažič J, Karner P, Vovko TD, Pečavar B, Volčanšek G, Poljak M, Abecasis AB.

BMC Infect Dis. 2015 Feb 15;15:65. doi: 10.1186/s12879-015-0802-6.

14.

Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.

Pingen M, Wensing AM, Fransen K, De Bel A, de Jong D, Hoepelman AI, Magiorkinis E, Paraskevis D, Lunar MM, Poljak M, Nijhuis M, Boucher CA; SPREAD programme.

Retrovirology. 2014 Nov 29;11:105. doi: 10.1186/s12977-014-0105-9.

15.

Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986-2013 update.

Škamperle M, Seme K, Lunar MM, Maver PJ, Tomažič J, Vovko TD, Pečavar B, Matičič M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):25-6.

16.

Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.

Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin-Devaux C, Verhofstede C, Wirden M, Amendola A, Boni J, Bourlet T, Huder JB, Karasi JC, Zidovec Lepej S, Lunar MM, Mukabayire O, Schuurman R, Tomazic J, Van Laethem K, Vandekerckhove L, Wensing AM; International Viral Load Assay Collaboration.

J Clin Microbiol. 2014 Feb;52(2):517-23. doi: 10.1128/JCM.02461-13. Epub 2013 Dec 4.

17.

The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.

Grgic I, Lepej SZ, Lunar MM, Poljak M, Vince A, Vrakela IB, Planinic A, Seme K, Begovac J.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):329-36. doi: 10.1089/AID.2012.0191. Epub 2012 Oct 4.

18.

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.

Lunar MM, Židovec Lepej S, Abecasis AB, Tomažič J, Vidmar L, Karner P, Vovko TD, Pečavar B, Maver PJ, Seme K, Poljak M.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):343-9. doi: 10.1089/AID.2012.0152. Epub 2012 Aug 29.

19.

Prevalence of HPV 16 genomic variant carrying a 63 bp duplicated sequence within the E1 gene in Slovenian women.

Bogovac Z, Lunar MM, Kocjan BJ, Seme K, Jančar N, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):135-9.

20.

Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008.

Seme K, Lunar MM, Tomazic J, Vidmar L, Karner P, Maticic M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2009 Dec;18(4):153-6.

21.

Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.

Seme K, Lepej SZ, Lunar MM, Iscić-Bes J, Planinić A, Kocjan BJ, Vince A, Poljak M.

J Clin Virol. 2009 Oct;46(2):176-9. doi: 10.1016/j.jcv.2009.07.017. Epub 2009 Aug 15.

PMID:
19683958
22.

Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Poljak M, Kocjan BJ, Kovanda A, Lunar MM, Lepej SZ, Planinic A, Seme K, Vince A.

J Clin Microbiol. 2009 Aug;47(8):2611-5. doi: 10.1128/JCM.00278-09. Epub 2009 Jun 3.

23.

Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.

Jancar N, Kocjan BJ, Poljak M, Lunar MM, Bokal EV.

Eur J Obstet Gynecol Reprod Biol. 2009 Aug;145(2):184-8. doi: 10.1016/j.ejogrb.2009.04.030. Epub 2009 May 23.

PMID:
19477061
24.

Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: a report of three cases.

Tesović G, Poljak M, Lunar MM, Kocjan BJ, Seme K, Vukić BT, Sternak SL, Cajić V, Vince A.

Vaccine. 2008 Apr 7;26(16):1922-5. doi: 10.1016/j.vaccine.2008.02.014. Epub 2008 Feb 22. No abstract available.

PMID:
18329761

Supplemental Content

Loading ...
Support Center